Results 141 to 150 of about 18,162 (243)

Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses. [PDF]

J Infect Dis
Li M, Truong K, Sharma S, Sun B, Chen M, Kimata JT, Wang J.   +6 more
europepmc   +1 more source

Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Zhang Y, Wu W, Yang M, Liu J, Wu H, Chen Y.   +5 more
europepmc   +1 more source

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort

, 2009
Linda Wittkop, Dominique Breilh, Djennifer Da Silva, P. Duffau, P. Mercié, Isabelle Raymond‐Letron, Guerric Anies, Heloísa Junqueira Fleury, M C Saux, François Dabis, Catherine Fagard, Rodolphe Thiébaut, Bernard Masquelier, I. Pellegrin   +13 more
openalex   +2 more sources

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

Euro Surveill
van Kampen J, Voermans J, Soochit W, Mesplède T, van de Laar T, van der Reijden W, Burger D, Shalev N, van Sighem A, Bezemer D, Jurriaans S, van der Vaart T, de Jong H, van der Valk M.   +13 more
europepmc   +1 more source

Addition of Etravirine Does Not Enhance the Initial Decline of HIV-1 RNA in Treatment-Experienced Patients Receiving Raltegravir

, 2017
Philippe Flandre, Anne‐Geneviève Marcelin, Vincent Cálvez, on behalf of the ANRS AC11 Resistance Study Group   +3 more
openalex   +2 more sources

Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants

, 2022
Robert A. Smith, Vincent H. Wu, Jennifer Song, Dana N. Raugi, Khardiata Diallo Mbaye, Moussa Seydi, Geoffrey S. Gottlieb   +6 more
openalex   +2 more sources

A case of under-dosing after raltegravir formulation change in an elderly patient treated for HIV

, 2019
S Kobayashi, Kenjiro Momo, Takeo Yasu, Saori Higashino, Shingo Kuroda   +4 more
openalex   +1 more source

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]

Int J Mol Sci
Gáspár Z, Lakatos B.
europepmc   +1 more source

Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome

, 2010
Ila Singh, John E. Gorzynski, Daria Drobysheva, Leda Bassit, Raymond F. Schinazi   +4 more
openalex   +2 more sources

Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]

J Exp Pharmacol
Rao AM, Sm F, Somashekara D, Gayam PKR, Rahangdale RR, Patil SS, Hariharapura RC.   +6 more
europepmc   +1 more source